UPA Advanced Metabolic Research Vial - Retatrutide (Upret 60) 60 mg Total | Multi-Dose Vial
R 3,200.00 ZAR
Skip to product information
UPA Advanced Metabolic Research Vial - Retatrutide (Upret 60) 60 mg Total | Multi-Dose Vial
R 3,200.00 ZAR
Product Overview
Upret 60 contains Retatrutide, a synthetic peptide compound supplied in vial format. Retatrutide is commonly referenced in research settings for its interaction with multiple metabolic and regulatory signalling pathways.
This vial format is intended for experienced users familiar with peptide handling, reconstitution, and compound protocols.
Compound Information
Retatrutide compound
Multi-pathway signalling interaction profile
Supplied in multi-dose vial format
Intended for controlled compound preparation
Format Information
Multi-Dose Vial
This product is supplied as a dry or prepared compound in vial format, allowing for flexible handling and measurement according to user-specific protocols.
General Research Context
Retatrutide has been explored in scientific literature relating to metabolic signalling pathways and receptor interaction frameworks.
No claims are made regarding appetite modulation, weight management, glucose control, insulin response, or therapeutic outcomes.
Storage & Handling
Store according to packaging instructions
Refrigeration recommended unless otherwise specified
Do not use if solution appears cloudy or contains particles
Handle using appropriate compound safety protocols
Intended Audience
This product is intended for experienced users familiar with peptide-based compounds, vial preparation, and laboratory-style handling practices.
Disclaimer
This product is not intended to diagnose, treat, cure, or prevent any disease.
Additional Disclaimer
All compound products are supplied for catalogue and informational purposes only. Customers are responsible for ensuring appropriate handling, preparation, and compliance with applicable regulations.